BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹2.54 Cr | ₹2.69 Cr | ₹1.07 Cr | ₹2.50 Cr | ₹2.44 Cr |
What is the latest Long Term Provisions ratio of BLISS GVS PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹2.54 Cr |
Mar2023 | ₹2.69 Cr |
Mar2022 | ₹1.07 Cr |
Mar2021 | ₹2.50 Cr |
Mar2020 | ₹2.44 Cr |
How is Long Term Provisions of BLISS GVS PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹2.54 Cr | -5.58 | |
Mar2023 | ₹2.69 Cr | 150.37 | |
Mar2022 | ₹1.07 Cr | -57.01 | |
Mar2021 | ₹2.50 Cr | 2.42 | |
Mar2020 | ₹2.44 Cr | - |
Compare Long Term Provisions of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,316.4 Cr | 7.3% | 9% | 10.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | 7.3% |
9% |
10.2% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses